What Is a 409A Valuation and Why Does Your Startup Need One?
A 409A valuation sets the fair market value of your company's common stock for option grants. It's your safe harbor against IRS challenge — and without it, the burden of proof falls on you. Here's how it works and when you need it.
A 409A valuation is an independent appraisal of your company's common stock fair market value. It's required before you can grant stock options to employees. Setting the exercise price below fair market value triggers Section 409A penalties — a 20% excise tax plus interest for the option holder, with no cap.
Why 409A Valuations Exist
Section 409A of the Internal Revenue Code governs deferred compensation, including stock options. The law requires that the exercise price of stock options be set at or above fair market value on the date of grant.
The problem: startup common stock isn't publicly traded, so there's no market price. A 409A valuation provides the IRS-defensible determination of fair market value that lets you grant options with confidence.
What Happens Without One
An important nuance: granting options without a third-party 409A valuation does not automatically trigger penalties. What it does is shift the burden of proof.
Safe Harbor vs. No Safe Harbor
With a qualified independent appraisal (the "safe harbor"), the IRS bears the burden of proving your valuation was grossly unreasonable. That's a high bar for the government to clear, and it provides significant protection.
Without a third-party valuation, the burden shifts to the company and board to prove the exercise price was set at fair market value using a reasonable methodology. You're not automatically penalized — but you're exposed. If the IRS challenges your valuation and you can't demonstrate that your methodology was reasonable, then 409A penalties kick in.
The Penalties (When They Apply)
If the exercise price is ultimately determined to be below fair market value:
- The option holder owes a 20% excise tax on the value of the option at vesting, plus interest dating back to when the option first vested. This is on top of regular income tax.
- The penalty is uncapped. There's no maximum — it applies to the full spread between the exercise price and fair market value.
- The company has reporting obligations and may face its own penalties for failure to withhold.
This penalty falls on the employee, not the company — which makes it particularly damaging to morale and recruiting when discovered.
Do You Need a 409A at the Earliest Stages?
This is one of the most common questions from very early-stage founders: "We're pre-revenue, pre-product, and have only raised on SAFEs. Do we really need to pay for a formal 409A?"
The answer is nuanced, and reasonable practitioners disagree.
The Case for a Board-Led Valuation at the Earliest Stage
Some experienced startup attorneys take the position that at the very earliest stage — pre-revenue, pre-product, with only SAFE or convertible note financing — a board-determined valuation can be defensible without a formal third-party appraisal.
The reasoning: SAFEs are convertible instruments, not priced equity. On the balance sheet, they're effectively a debit and credit — cash received against a convertible liability (or equity-classified instrument). They don't set a price per share for common stock. At this stage, the company has minimal assets beyond cash (which belongs to the entity, not the common stockholders after accounting for the SAFE obligation), no revenue, and often no product. A board resolution setting common stock at par value or nominal value, with documented reasoning, can constitute a "reasonable" valuation methodology under the regulations.
The Risk
Without the safe harbor, you're betting that your board's methodology holds up if challenged. For most founders making their first few option grants to early team members (at very low exercise prices), the practical risk is low — the IRS has limited incentive to challenge a $0.01/share exercise price at a pre-product startup. But as the company matures, the risk profile changes.
Our Recommendation
If your company is truly pre-revenue, pre-product, and has only raised on SAFEs or notes, a board-led valuation with documented methodology is a defensible approach for your earliest option grants. But get a formal 409A before any of the following:
- You close a priced equity round (the pricing creates a clear fair market value data point)
- You have meaningful revenue
- You've been operating for more than 12-18 months
- You're making significant option grants (VP-level or above)
- An investor requires it
The cost of a 409A ($1,000-$3,000) is low relative to the protection it provides. When in doubt, get one.
When You Need a 409A
Before Your First Option Grant (or Close to It)
For most companies, having a 409A before your first option grant is best practice. At the very earliest stage, a board-determined valuation may suffice (see above), but a formal 409A provides the safe harbor protection that removes uncertainty.
After a Material Event
A new 409A is needed after events that significantly change the company's value:
- Closing a financing round (SAFE, note, or priced equity)
- Significant revenue milestones
- Launching a new product
- Material changes in the business
At Least Annually
Even without a material event, 409A valuations must be refreshed at least every 12 months to maintain their "safe harbor" protection.
The Safe Harbor
The IRS provides a "safe harbor" for 409A valuations — meaning the IRS presumes the valuation is reasonable and the burden shifts to the IRS to prove otherwise. To qualify for safe harbor, the valuation must be:
- Performed by a qualified independent appraiser (not your accountant or CFO)
- Based on a recognized valuation methodology (income approach, market approach, or asset approach)
- Dated within 12 months of the option grant (and no material event has occurred since)
Without safe harbor protection, the IRS can challenge your exercise price and retroactively impose 409A penalties on every option holder.
How the Valuation Works
What the Appraiser Looks At
- Financial statements and projections
- Recent financing rounds (SAFE valuations, priced rounds)
- Revenue and growth metrics
- Comparable company analysis (public companies and recent transactions)
- Stage of development and risk factors
- Discount for lack of marketability (DLOM) — common stock can't be freely sold, so it's worth less than preferred stock
Common Stock vs. Preferred Stock
A 409A values common stock specifically, not the company as a whole. Preferred stock (held by investors) has liquidation preferences, anti-dilution protections, and other rights that make it more valuable than common stock. The 409A applies a discount to reflect this difference.
For early-stage startups, the common stock value is typically 20-35% of the preferred stock price per share. As companies mature and approach exit, this discount narrows.
Typical 409A Values by Stage
| Stage | Common Stock as % of Last Round Price |
|---|---|
| Pre-revenue, post-seed | 15-25% |
| Early revenue, post-Series A | 25-40% |
| Scaling, post-Series B | 40-60% |
| Late stage / pre-IPO | 60-90% |
These are rough benchmarks — actual valuations depend on company-specific factors.
Cost and Timeline
Cost
- Early-stage startups: $1,000-$3,000 per valuation
- Growth-stage companies: $3,000-$8,000
- Providers: Carta (integrated with cap table), Scalar, Eton Venture Services, Aranca
Most cap table platforms like Carta offer 409A valuations as a bundled service, which simplifies the process.
Timeline
- Initial valuation: 2-4 weeks
- Updates: 1-2 weeks (less diligence required)
Plan ahead. If you're hiring and need to make option grants, start the 409A process early so you're not waiting to make offers.
Common Mistakes
Granting Options Before the 409A Is Complete
"We'll backdate the grant to when we started the valuation" is not how this works. Options must be granted at the board-approved exercise price, which must be based on a completed 409A. Grant date is grant date.
Using a Stale Valuation After a Financing
Your pre-financing 409A is no longer valid after you close a round. The financing is a material event that requires a new valuation. Granting options in the weeks after a financing using the old 409A is a common and expensive mistake.
Setting the Price Without Any Methodology
"We decided the stock is worth $0.50 based on our last SAFE cap" is not a defensible valuation. While you don't strictly need a third-party appraisal to grant options, you do need a reasonable methodology with documented reasoning. A SAFE valuation cap is not the fair market value of common stock — common stock sits below SAFEs and preferred stock in the liquidation stack and should be valued accordingly. Without either a formal 409A or a well-documented board methodology, you're outside the safe harbor with no clear defense.
Not Refreshing Annually
The 12-month clock is strict. If your last 409A is 13 months old and you grant options, you've lost safe harbor protection for those grants even if nothing material has changed.
409A and Fundraising Timing
Here's a practical tip: the best time to grant options is immediately after a 409A that follows a fundraise. At that point, the common stock value has been freshly assessed, and you have maximum certainty about the exercise price.
If you're planning a large batch of option grants (for a hiring wave, for example), coordinate the timing with your 409A refresh to ensure you're granting at a defensible price.
Bottom Line
The 409A valuation is not optional. It's a regulatory requirement that protects your employees from punitive tax penalties. Budget for it, time it correctly, and never grant options without one.
Get it done before your first option grant, refresh it after every financing, and keep it current annually. It's one of the lowest-cost, highest-consequence compliance items on your legal checklist.
Need help coordinating your 409A and option grants? Book a free call — equity administration is part of every Flux plan.
Need legal guidance for your startup?
Book a free intro call and see how Flux can help.
Book a Free Call